Physician Assistant · Tyler, TX
NPI
1669722393
Since 2012
Specialty
Physician Assistant
Code 363A00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
5777 New Copeland Rd, Suite 100
Tyler, TX, 75703
Phone (903) 561-9255
Groups this clinician bills Medicare through
Medicare paid, 2024
$882K
71,216 services
Medicare patients, 2024
809
Average age 73
Drug cost, 2024
$6.3M
8,957 prescriptions
Company payments, 2025
$883
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Scott A Phillips was code J1010 (injection, methylprednisolone acetate, 1 mg), 27,064 times for 229 patients. In total Scott A Phillips billed 71,216 services in 66 codes, and Medicare paid $882K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-11-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 27,064 | 229 | $0.10 | $2,765 |
| J3262 Injection, tocilizumab, 1 mg | Office | 13,220 | 14 | $4.73 | $63K |
| 86235 Immunoassay | Office | 6,056 | 538 | $17.55 | $106K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 5,500 | 24 | $33.85 | $186K |
| Q5104 Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | Office | 5,150 | 45 | $23.41 | $121K |
| 83516 Immunoassay | Office | 1,510 | 536 | $11.29 | $17K |
| 99213 Office E&M - Established | Office | 1,418 | 769 | $50.20 | $71K |
| J0897 Injection, denosumab, 1 mg | Office | 960 | 14 | $21.16 | $20K |
| 86225 Immunoassay | Office | 756 | 537 | $13.46 | $10K |
| 86226 Immunoassay | Office | 756 | 537 | $11.86 | $8,965 |
| 86431 Immunoassay | Office | 756 | 536 | $5.55 | $4,199 |
| 86200 Immunoassay | Office | 755 | 536 | $12.68 | $9,571 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 662 | 463 | $10.05 | $6,656 |
| 96415 Chemotherapy Administration | Office | 281 | 67 | $16.78 | $4,716 |
| 20611 Joint Injection | Office | 233 | 161 | $69.97 | $16K |
By year: 2022 $23K for 1,175 services; 2023 $601K for 28,581 services; 2024 $882K for 71,216 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 6,056 | 538 | $17.55 | $106K |
| 83516 Immunoassay | 1,510 | 536 | $11.29 | $17K |
| 86225 Immunoassay | 756 | 537 | $13.46 | $10K |
| 86226 Immunoassay | 756 | 537 | $11.86 | $8,965 |
| 86431 Immunoassay | 756 | 536 | $5.55 | $4,199 |
| 86200 Immunoassay | 755 | 536 | $12.68 | $9,571 |
Medicare prescription drug claims, 2024
In 2024, the drug Scott A Phillips prescribed most often to Medicare patients was Prednisone, with 2,171 prescriptions and refills. In total Scott A Phillips wrote 8,957 Medicare prescriptions that cost $6.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisone Generic | 2,171 | 3,410 | 607 | $12K |
| Hydroxychloroquine Sulfate Generic | 825 | 1,329 | 194 | $27K |
| Tramadol Hcl Generic | 689 | 700 | 161 | $6,037 |
| Methotrexate Methotrexate Sodium | 650 | 1,206 | 168 | $12K |
| Allopurinol Generic | 464 | 940 | 124 | $2,921 |
| Celecoxib Generic | 428 | 631 | 112 | $17K |
| Gabapentin Generic | 407 | 665 | 102 | $4,669 |
| Meloxicam Generic | 318 | 509 | 84 | $992 |
| Duloxetine Hcl Generic | 301 | 596 | 100 | $5,117 |
| Enbrel Sureclick Etanercept | 231 | 238 | 27 | $1.8M |
| Cyclobenzaprine Hcl Generic | 189 | 259 | 53 | $1,067 |
| Sulfasalazine Dr Sulfasalazine | 179 | 293 | 48 | $5,084 |
| Methylprednisolone Generic | 173 | 244 | 69 | $2,440 |
| Humira(Cf) Pen Adalimumab | 172 | 186 | 29 | $2.0M |
| Leflunomide Generic | 171 | 302 | 51 | $7,554 |
Brand drugs: - claims; generic drugs: 7,895 claims; opioid claims: 719.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Scott A Phillips $883 ($883 in general payments such as food, travel and fees) from 17 companies. The largest payer was Abbvie Inc. with $159.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 6 | $159 |
| BSN Medical Inc | 2 | $144 |
| Amgen Inc. AMGN | 6 | $122 |
| Bioventus LLC BVS | 3 | $65.03 |
| GlaxoSmithKline, LLC. GSK | 2 | $49.89 |
| Fresenius Kabi USA, LLC | 2 | $42.78 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $40.54 |
| Janssen Biotech, Inc. JNJ | 2 | $35.89 |
| ANI Pharmaceuticals, Inc. ANIP | 1 | $32.7 |
| Mallinckrodt Hospital Products Inc. | 1 | $31.31 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.